Biogenysis (@biogenysisinc) 's Twitter Profile
Biogenysis

@biogenysisinc

At Biogenysis, we employ state-of-the-art AI technology to discover new drugs, create diagnostic tools, & enhance medical treatments for human & animal diseases

ID: 1672344558862991360

calendar_today23-06-2023 20:43:35

9 Tweet

901 Followers

26 Following

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

We get a powerful boost equivalent to 1000 suns. As Joel A Barker said, having a vision is only enough to take action, and taking action without a vision is pointless. However, when vision and action are combined, they have the power to change the world. finance.yahoo.com/news/enzolytic…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

As we advance, we recognize that it requires the efforts of many individuals. Our family continues to expand with a shared sense of purpose, integrity, & a clear vision for the future #ENZC #SAGA #BGEN #SAMSUNGBIOLOGICS #TWIST otcmarkets.com/stock/SAGA/new…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

As we celebrate Independence Day, we acknowledge and pay tribute to the sacrifices made by those who fought for our freedom. The courage displayed by America's heroes in standing up for what they believed in is remembered. We wish you a Happy #independenceday23 #ENZC #BGEN

As we celebrate Independence Day, we acknowledge and pay tribute to the sacrifices made by those who fought for our freedom. The courage displayed by America's heroes in standing up for what they believed in is remembered. We wish you a Happy #independenceday23 #ENZC  #BGEN
Biogenysis (@biogenysisinc) 's Twitter Profile Photo

Successful companies are the result of yrs of commitment, dedication & vision #BGEN aims to achieve such success by integrating its #AI & Monoclonal Antibody platforms. With a clear purpose & unwavering determination, we march towards our goals #ENZC finance.yahoo.com/news/enzolytic…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

#BGEN is strategically pursuing collaborations, licensing, & partnerships for 19 viruses. According to Polaris Market Research, the global market size for #MonoclonalAntibodies is projected to reach $ 479.13 billion by 2030. strategic IP portfolio #AI nasdaq.com/press-release/…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

The Company has executed a binding business combination agreement for the purchase of #BGEN & VIRO, operating subsidiaries of Enzolytics Inc. #ENZC The combined company is expected to trade on NASDAQ. finance.yahoo.com/news/sagaliam-…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

We have a well-defined strategy and the necessary technology in place for producing numerous therapeutics for successfully treating numerous viruses. Completing the business combination with Sagaliam comes at a critical time. nasdaq.com/press-release/…

Biogenysis (@biogenysisinc) 's Twitter Profile Photo

We are excited to share that our website is now live at biogenysis.com Our portfolio of #mab is on display, and we are thrilled to introduce the #Chandradrishti #AI Platform. It showcases our unwavering commitment to our vision, strategic plan, & talented team involved.